CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Taiwan

3 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Shin Kong Wu Ho Su Memorial Hospital, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-11-03
NCT06859099
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Trial Treatment · Phase 3 · Sanofi
Investigational Site Number : 1580001, Taipei
Registry updated 2026-10-27
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Investigational Site Number : 1580003, Kaohsiung City · Investigational Site Number : 1580001, Taipei · Investigational Site Number : 1580002, Taipei
Registry updated 2026-10-19

This page is not medical advice. Talk to your doctor before contacting a trial.

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)